Guangdong Transtek Medical Electronics Co., Ltd (SHE:300562)
China · Delayed Price · Currency is CNY 14.65
-0.12 (-0.81%)
Feb 13, 2026, 3:04 PM CST
SHE:300562 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 978.81 | 978.02 | 878.91 | 1,060 | 1,816 | 1,333 |
Other Revenue | 5.96 | 5.96 | 5.35 | 4.97 | 4.82 | 3.89 |
| 984.77 | 983.98 | 884.26 | 1,065 | 1,821 | 1,337 | |
Revenue Growth (YoY) | -4.63% | 11.28% | -16.98% | -41.51% | 36.23% | 51.27% |
Cost of Revenue | 651.46 | 645.88 | 606.35 | 844.21 | 1,486 | 1,001 |
Gross Profit | 333.31 | 338.1 | 277.9 | 220.88 | 335.31 | 335.48 |
Selling, General & Admin | 159.03 | 182.25 | 144.41 | 133.42 | 172.94 | 146.04 |
Research & Development | 92.52 | 96.81 | 108.32 | 136.93 | 149.15 | 96.52 |
Other Operating Expenses | 5.48 | 6.65 | 7.11 | 10.05 | 5.77 | 3.75 |
Operating Expenses | 257.51 | 286.7 | 263.69 | 285.62 | 335.22 | 250.93 |
Operating Income | 75.8 | 51.39 | 14.22 | -64.74 | 0.09 | 84.55 |
Interest Expense | -5.73 | -5.35 | -4.28 | -2.42 | -2.57 | -0.38 |
Interest & Investment Income | 10.36 | 7.65 | 9.95 | 7.07 | 11.41 | 1.74 |
Currency Exchange Gain (Loss) | 17.23 | 17.23 | 7.09 | 29.91 | -9.63 | -21.87 |
Other Non Operating Income (Expenses) | -8.93 | -0.23 | 0.02 | -0.63 | -1.31 | -0.67 |
EBT Excluding Unusual Items | 88.73 | 70.7 | 27.01 | -30.81 | -2.01 | 63.37 |
Impairment of Goodwill | -8.55 | -8.55 | - | -3.44 | -4.78 | - |
Gain (Loss) on Sale of Investments | 3.84 | -0.14 | 0.79 | -6.31 | 0.22 | -0.52 |
Gain (Loss) on Sale of Assets | 0.17 | 0.09 | -0.47 | 0.38 | -0.05 | - |
Asset Writedown | -7.8 | -4.29 | -0.86 | -12.77 | -3.34 | -0.02 |
Other Unusual Items | 1.55 | 2.22 | 6.64 | 8.39 | 6.76 | 9.1 |
Pretax Income | 77.94 | 60.04 | 33.11 | -44.57 | -3.21 | 71.93 |
Income Tax Expense | 3.21 | 1.88 | 1.91 | -6.37 | -2.93 | 4.03 |
Earnings From Continuing Operations | 74.73 | 58.16 | 31.2 | -38.2 | -0.28 | 67.89 |
Minority Interest in Earnings | 1.79 | 3.21 | 3.17 | 5.84 | 9.14 | 2.27 |
Net Income | 76.52 | 61.36 | 34.37 | -32.36 | 8.87 | 70.16 |
Net Income to Common | 76.52 | 61.36 | 34.37 | -32.36 | 8.87 | 70.16 |
Net Income Growth | 9.76% | 78.55% | - | - | -87.36% | 125.86% |
Shares Outstanding (Basic) | 217 | 217 | 215 | 216 | 222 | 190 |
Shares Outstanding (Diluted) | 217 | 217 | 215 | 216 | 222 | 190 |
Shares Change (YoY) | 1.03% | 0.87% | -0.24% | -2.70% | 16.93% | -2.33% |
EPS (Basic) | 0.35 | 0.28 | 0.16 | -0.15 | 0.04 | 0.37 |
EPS (Diluted) | 0.35 | 0.28 | 0.16 | -0.15 | 0.04 | 0.37 |
EPS Growth | 8.64% | 77.02% | - | - | -89.19% | 131.25% |
Free Cash Flow | 130.73 | 90.87 | 61.25 | 63.61 | -68.66 | -21.3 |
Free Cash Flow Per Share | 0.60 | 0.42 | 0.28 | 0.29 | -0.31 | -0.11 |
Dividend Per Share | 0.280 | 0.280 | 0.150 | 0.010 | 0.010 | 0.200 |
Dividend Growth | - | 86.67% | 1400.00% | - | -95.00% | 809.27% |
Gross Margin | 33.85% | 34.36% | 31.43% | 20.74% | 18.41% | 25.10% |
Operating Margin | 7.70% | 5.22% | 1.61% | -6.08% | 0.01% | 6.33% |
Profit Margin | 7.77% | 6.24% | 3.89% | -3.04% | 0.49% | 5.25% |
Free Cash Flow Margin | 13.28% | 9.23% | 6.93% | 5.97% | -3.77% | -1.59% |
EBITDA | 91.38 | 70.53 | 38.09 | -40.77 | 18.35 | 99.26 |
EBITDA Margin | 9.28% | 7.17% | 4.31% | -3.83% | 1.01% | 7.42% |
D&A For EBITDA | 15.58 | 19.13 | 23.87 | 23.97 | 18.26 | 14.71 |
EBIT | 75.8 | 51.39 | 14.22 | -64.74 | 0.09 | 84.55 |
EBIT Margin | 7.70% | 5.22% | 1.61% | -6.08% | 0.01% | 6.33% |
Effective Tax Rate | 4.12% | 3.14% | 5.78% | - | - | 5.61% |
Revenue as Reported | 984.77 | 983.98 | 884.26 | 1,065 | 1,821 | 1,337 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.